1. Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer
   Yohei Hisada et al, 2021, Cancers CrossRef
2. Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study
   Kan Yonemori et al, 2022, Cancer Science CrossRef
3. Place des thérapies innovantes dans la prise en charge des cancers du col de l’utérus
   Diana Bello Roufai, 2024, Bulletin du Cancer CrossRef
4. Prostate Cancer Secretome and Membrane Proteome from Pten Conditional Knockout Mice Identify Potential Biomarkers for Disease Progression
   Nilton J. Santos et al, 2022, International Journal of Molecular Sciences CrossRef
5. Exposure‐safety and exposure‐efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors
   Chaitali Passey et al, 2023, CPT: Pharmacometrics & Systems Pharmacology CrossRef
6. Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy
   Alexander C. Cohen et al, 2020, Drugs CrossRef
7. A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer
   An-Jin Wang et al, 2022, Frontiers in Pharmacology CrossRef